Press Release – Santa Monica, CA and Salt Lake City, Utah – Nov. 2, 2017 – PancreaCell a startup incubating within the Leonhardt’s Launchpads accelerators in California and Utah announced today it has made it to the final 10 of The American Diabetes Association’s 22nd Annual Leaders Forum HealthTech Showcase NATIONAL PITCH CONTEST.
Tomorrow morning in San Francisco the 10 finalists will compete to make it to the final 3 which will compete again later in the day for the Grand Prize at a luncheon hosted by the Silicon Valley Leaders Forum – to purchase tickets click here > http://main.diabetes.org/site/Calendar?view=Detail&id=52568
2017 Silicon Valley Leaders Forum HealthTech Showcase
Marriott Hotel
The American Diabetes Association’s 22nd Annual Leaders Forum HealthTech Showcase is an opportunity to network with over 400 Bay Area biotech, venture capital and investment banking executives. Participatants in our HealthTech Showcase will features start-up ventures in the life science and digital health arenas. Enjoy the presentations and luncheon while taking part in deciding which of the three start-up finalists will be awarded the top honors. If you have any questions, please contact Linda Mayberry at lmayberry@diabetes.org
Date: Friday, November 3, 2017
Time: 10:30 AM – 1:30 PM
Address:
1770 South Amphlett Blvd.
San Mateo, CA 94402
“We are honored to be selected to be among the finalists in this esteemed competition” stated Dr. Harish Kapoor, President of PancreaCell and DDC
PancreaCell teamed with Dedicated Diabetic Coaches (DDC), VascuStim and InStim to create a Total Diabetes Management program.
- PancreaCell is focused on pancreas regeneration with a combination bioelectric stimulator + micro infusion pump + 15 component PC-15 stem cell and growth factor based regeneration composition.
- DDC is focused on analytics based diabetes management with a variety of tools.
- VascuStim is focused on bioelectric and amniotic fluid membrane treatment of lower limb diabetic ulcers.
- InStim is focused on real time bioelectric inflammation management.
“More and more studies are coming out supporting the value of bioelectric, stem cell and growth factors based organ regeneration as well as personalized medicine. Our team is striving to lead in combining these modalities into a comprehensive diabetes recovery protocol. We feel humbled that the American Diabetes Association has recognized our work in inviting us to the finals of this national competition in San Francisco.” states Howard J. Leonhardt, Lead Inventor, Executive Chairman & CEO
Link to the PancreaCell DDC Slide Deck – https://app.slidebean.com/p/j5ApppWU7u/PancreaCell-2
For more Information see www.lventuresnestg.wpenginepowered.com + https://leonhardtventures.com/pancreacell/